1Information Technology and Cyber Security, Innovative Knowledge Institute, Paris, France
Corresponding Author: Christos Beretas, MSc
Address: Information Technology and Cyber Security, Innovative Knowledge Institute, Paris, France; Tel: (+33) 173-481-442, (+30) 693-890-9477; E-mail: firstname.lastname@example.org
Received date: 17 November 2019; Accepted date: 14 January 2020; Published date: 30 January 2020
Objective: Pump size exterior artificial pancreas that will keep the glucose between 120 – 150mg/dl.
Method: The whole project based on the idea that we should already know one insulin unit how much is able to go down the glucose and one glucagons unit how much is able to increase the glucose. Less than 120 mg/dl it uses glucagons. More than 150 mg/dl it uses insulin. The pump checks the glucose automatically for every 8 minutes. The pump (which is software decision) will choose between insulin or glucagons base in an internal database table with prerequisite glucose values and the insulin or glucagons units requiring for each glucose value (adaptive database table for each diabetic). The pump (the software) is able to choose how many insulin or glucagon units it should use (that is not based on what the diabetic will eat, but base on the current glucose level that received from the sensor which is located in the human body, needle and sensor are one piece). The insulin should have a work duration of 8 minutes and works instantly.
Result: I choose 120 mg/dl as the lowest allowance glucose level as this level is secure for the diabetic (there is a time to prevent big hypoglycemia).
Conclusion: This project offers to diabetics insulin injections freedom, hypoglycemia prevention, run emergency tests, ideally for all ages, endocrinologists will have the software to adapt the internal database table of the pump for each diabetic needs.
Citation: Beretas C. Exterior Artificial Pancreas Project. Diab Res Open Access. 2020 Jan 30;2(1):1-3.
Copyright © 2020 Beretas C. This is an open-access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Keywords: Artificial Pancreas; Glucagon; Insulin; Diabetes